Flag of the European Union EU Clinical Trials Register Help

Clinical trials for Female sexual dysfunction

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

    • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).

    The EU Clinical Trials Register currently displays   44334   clinical trials with a EudraCT protocol, of which   7366   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    115 result(s) found for: Female sexual dysfunction. Displaying page 1 of 6.
    1  2  3  4  5  6  Next»
    EudraCT Number: 2006-004397-27 Sponsor Protocol Number: 310741 Start Date*: 2007-10-19
    Sponsor Name:Bayer Schering Pharma AG
    Full Title: Multi-center, double-blind, placebo-controlled study to investigate the efficacy and safety of daily oral 100 mg dehydroepiandrosterone (DHEA) over 6 treatment cycles as a concomitant therapy to or...
    Medical condition: Multi-center, double-blind, placebo-controlled study to investigate the efficacy and safety of daily oral 100 mg dehydroepiandrosterone (DHEA) over 6 treatment cycles as a concomitant therapy to or...
    Disease: Version SOC Term Classification Code Term Level
    9.1 10040477 Sexual dysfunction LLT
    Population Age: Adults Gender: Female
    Trial protocol: DE (Completed)
    Trial results: View results
    EudraCT Number: 2013-001966-40 Sponsor Protocol Number: CD001 Start Date*: 2014-01-27
    Sponsor Name:Companion Diagnostics BV
    Full Title: A double blind, randomized, placebo controlled, cross-over, Lybridos dose finding study to validate the predictive power of the diagnostic model for Lybrido and Lybridos efficacy and to identify an...
    Medical condition: Hypoactive Sexual Desire Disorder/SSRI-induced sexual dysfunction
    Disease: Version SOC Term Classification Code Term Level
    14.1 100000004873 10040470 Sexual desire disorders HLT
    14.1 100000004873 10020933 Hypoactive sexual desire disorder LLT
    Population Age: Adults, Elderly Gender: Female
    Trial protocol: NL (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2007-000013-10 Sponsor Protocol Number: PR3042 Start Date*: 2007-03-14
    Sponsor Name:Pantarhei Bioscience B.V.
    Full Title: A double-blind, placebo controlled, randomised, comparative 2-way crossover study to determine the effect of concomitant treatment with dehydroepiandrosterone (50 mg) on sexual arousability and the...
    Medical condition: Sexual dysfunction caused by the use of oral contraceptives
    Disease: Version SOC Term Classification Code Term Level
    9.1 10057671 Female sexual dysfunction LLT
    Population Age: Adults Gender: Female
    Trial protocol: NL (Completed)
    Trial results: View results
    EudraCT Number: 2008-007704-28 Sponsor Protocol Number: EB77 Start Date*: 2009-01-21
    Sponsor Name:Emotional Brain
    Full Title: Lybridos PoC: A double blind, randomized, cross-over placebo controlled pilot study to investigate the subjective and physiological efficacy and safety of Lybridos in healthy female subjects with F...
    Medical condition: Female Sexual Dysfunction, specifically Hypoactive Sexual Desire Disorder, with or without Female Sexual Arousal Disorder.
    Disease: Version SOC Term Classification Code Term Level
    9.1 10020933 Hypoactive sexual desire disorder LLT
    Population Age: Adults, Elderly Gender: Female
    Trial protocol: NL (Prematurely Ended)
    Trial results: (No results available)
    EudraCT Number: 2009-016790-15 Sponsor Protocol Number: EB78 Start Date*: 2009-12-03
    Sponsor Name:Emotional Brain
    Full Title: A double blind, randomized, cross-over placebo controlled study to investigate the subjective and physiological efficacy and safety of Lybrido and Lybridos in the domestic setting in healthy female...
    Medical condition: Hypoactive Sexual Desire Disorder (comorbidity with other sexual dysfunctions e.g Female Sexual Arousal Disorder (FSAD) is allowed) and/or SSRI induced sexual dysfunctioning.
    Disease:
    Population Age: Adults, Elderly Gender: Female
    Trial protocol: NL (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2008-002735-32 Sponsor Protocol Number: EB72 Start Date*: 2008-06-24
    Sponsor Name:Emotional Brain
    Full Title: A double blind, randomized, placebo controlled cross-over study to investigate the subjective and physiological efficacy and safety of Lybrido and Lybridos in the domestic setting in healthy female...
    Medical condition: Hypoactive sexual desire disorder and female sexual arousal disorder in combination with SSRI use.
    Disease:
    Population Age: Adults, Elderly Gender: Female
    Trial protocol: NL (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2010-019540-39 Sponsor Protocol Number: EB80 Start Date*: 2010-05-12
    Sponsor Name:Emotional Brain
    Full Title: A double blind, randomized, cross-over placebo controlled study to investigate the efficacy of sublingual testosterone solution on physiological and subjective arousal in healthy, sexually dysfunct...
    Medical condition: This pharmacodynamic trial will be conducted in sexually dysfunctional otherwise healthy women, but it is a part of a developmental program for medicine for Hypoactive Sexual Desire Disorder (comor...
    Disease: Version SOC Term Classification Code Term Level
    12.1 10040466 Sexual arousal disorders HLT
    12.1 10040470 Sexual desire disorders HLT
    12.1 10040478 Sexual dysfunction NEC HLT
    12.1 10020933 Hypoactive sexual desire disorder LLT
    12.1 10037228 Psychosexual dysfunction with inhibited sexual desire LLT
    12.1 10059272 Sexual desire decreased LLT
    12.1 10040465 Sexual arousal decreased LLT
    12.1 10058929 Disturbance in sexual arousal LLT
    12.1 10062641 Female sexual arousal disorder LLT
    12.1 10058929 Disturbance in sexual arousal PT
    12.1 10062641 Female sexual arousal disorder PT
    Population Age: Adults Gender: Female
    Trial protocol: NL (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2006-002922-51 Sponsor Protocol Number: H6D-MC-LVGH Start Date*: 2006-10-16
    Sponsor Name:Lilly ICOS LLC
    Full Title: Tadalafil 5 mg Once a Day Compared to Placebo in Improving Erectile Dysfunction and Sexual Quality of Life
    Medical condition: Erectile Dysfunction
    Disease: Version SOC Term Classification Code Term Level
    8.1 10061461 Erectile dysfunction LLT
    Population Age: Adults, Elderly Gender: Male
    Trial protocol: DE (Completed) AT (Completed) FR (Completed)
    Trial results: View results
    EudraCT Number: 2010-019285-86 Sponsor Protocol Number: EB79 Start Date*: 2010-05-07
    Sponsor Name:Emotional Brain
    Full Title: A single blind, randomized, cross-over placebo controlled dose finding study to investigate the pharmacokinetic profile of 3 doses of sublingual testosterone solution and their effect on physiologi...
    Medical condition: This pharmacokinetic trial will be conducted in healthy women, but it is a part of a developmental program for medicine for Hypoactive Sexual Desire Disorder (comorbidity with other sexual dysfunct...
    Disease: Version SOC Term Classification Code Term Level
    12.1 10040466 Sexual arousal disorders HLT
    12.1 10040470 Sexual desire disorders HLT
    12.1 10040478 Sexual dysfunction NEC HLT
    12.1 10020933 Hypoactive sexual desire disorder LLT
    12.1 10037228 Psychosexual dysfunction with inhibited sexual desire LLT
    12.1 10059272 Sexual desire decreased LLT
    12.1 10040465 Sexual arousal decreased LLT
    12.1 10058929 Disturbance in sexual arousal LLT
    12.1 10062641 Female sexual arousal disorder LLT
    12.1 10058929 Disturbance in sexual arousal PT
    12.1 10062641 Female sexual arousal disorder PT
    Population Age: Adults Gender: Female
    Trial protocol: NL (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2017-000960-14 Sponsor Protocol Number: FM57 Start Date*: 2018-12-19
    Sponsor Name:Futura Medical Developments Ltd.
    Full Title: A Phase III, dose ranging, multi-centre, randomised, double blind, placebo controlled, home use, parallel group clinical trial of topically-applied glyceryl trinitrate (GTN) for the treatment of er...
    Medical condition: Erectile dysfunction
    Disease: Version SOC Term Classification Code Term Level
    20.0 10038604 - Reproductive system and breast disorders 10061461 Erectile dysfunction PT
    20.0 10038604 - Reproductive system and breast disorders 10015116 Erectile disturbance LLT
    20.0 10038604 - Reproductive system and breast disorders 10025503 Male erectile disorder LLT
    20.0 10038604 - Reproductive system and breast disorders 10052003 Erectile dysfunction NOS LLT
    Population Age: Adults, Elderly Gender: Male
    Trial protocol: LV (Prematurely Ended) HU (Prematurely Ended) SK (Completed) PL (Prematurely Ended) CZ (Completed)
    Trial results: View results
    EudraCT Number: 2007-007620-17 Sponsor Protocol Number: PR3083 Start Date*: 2008-02-19
    Sponsor Name:Pantarhei Bioscience BV
    Full Title: A double-blind, placebo-controlled, randomized, N=1 study to determine the effect of concomitant treatment with dehydroepiandrosterone (50 mg) on sexual functioning in 6 women who experience a decr...
    Medical condition: Sexual dysfunction caused by the use of oral contraceptives
    Disease: Version SOC Term Classification Code Term Level
    9.1 10057671 Female sexual dysfunction LLT
    Population Age: Adults Gender: Female
    Trial protocol: NL (Completed)
    Trial results: View results
    EudraCT Number: 2011-002770-23 Sponsor Protocol Number: EB91 Start Date*: 2011-07-04
    Sponsor Name:Emotional Brain BV
    Full Title: A double-blind, randomized, placebo-controlled, proof of concept study to investigate the safety and efficacy of the combined administration of 0.5 mg sublingual testosterone and 10 mg tadalafil in...
    Medical condition: Hypoactive Sexual Desire Disorder
    Disease: Version SOC Term Classification Code Term Level
    13.1 10037175 - Psychiatric disorders 10059272 Sexual desire decreased LLT
    13.1 10037175 - Psychiatric disorders 10020933 Hypoactive sexual desire disorder LLT
    13.1 10037175 - Psychiatric disorders 10037228 Psychosexual dysfunction with inhibited sexual desire LLT
    13.1 10037175 - Psychiatric disorders 10040465 Sexual arousal decreased LLT
    Population Age: Adults Gender: Female
    Trial protocol: NL (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2012-003543-30 Sponsor Protocol Number: EB93 Start Date*: 2012-08-24
    Sponsor Name:Emotional Brain BV
    Full Title: A double-blind, randomized, placebo-controlled, proof of concept study to investigate the differences between the combined administration of 0.5 mg sublingual testosterone and 10 mg buspirone and 1...
    Medical condition: Hypoactive Sexual Desire Disorder Sexual Interest/Arousal Disorder
    Disease: Version SOC Term Classification Code Term Level
    14.1 10037175 - Psychiatric disorders 10037228 Psychosexual dysfunction with inhibited sexual desire LLT
    14.1 10037175 - Psychiatric disorders 10059272 Sexual desire decreased LLT
    14.1 10037175 - Psychiatric disorders 10040465 Sexual arousal decreased LLT
    14.1 10037175 - Psychiatric disorders 10058929 Disturbance in sexual arousal PT
    14.1 10037175 - Psychiatric disorders 10040470 Sexual desire disorders HLT
    14.1 10037175 - Psychiatric disorders 10040466 Sexual arousal disorders HLT
    14.1 10037175 - Psychiatric disorders 10020933 Hypoactive sexual desire disorder LLT
    14.1 10038604 - Reproductive system and breast disorders 10062641 Female sexual arousal disorder PT
    Population Age: Adults Gender: Female
    Trial protocol: NL (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2012-002047-26 Sponsor Protocol Number: FDC116115 Start Date*: 2012-10-03
    Sponsor Name:GlaxoSmithKline Research & Development Limited
    Full Title: FDC116115: A prospective study of sexual function in sexually active men treated for BPH
    Medical condition: BPH (Benign prostatic hyperplasia)
    Disease: Version SOC Term Classification Code Term Level
    15.0 10038604 - Reproductive system and breast disorders 10038604 Reproductive system and breast disorders SOC
    15.0 10038604 - Reproductive system and breast disorders 10004446 Benign prostatic hyperplasia PT
    Population Age: Adults, Elderly Gender: Male
    Trial protocol: GR (Completed) NL (Completed) HU (Completed) ES (Completed) DE (Completed)
    Trial results: View results
    EudraCT Number: 2007-007580-24 Sponsor Protocol Number: EB70 Start Date*: 2008-02-08
    Sponsor Name:Emotional Brain
    Full Title: A double blind, randomized, 3-arm placebo controlled study to investigate the subjective and physiological efficacy and safety of Lybrido and Lybridos in the domestic setting in healthy female subj...
    Medical condition: Hypoactive sexual desire disorder and female sexual arousal disorder
    Disease:
    Population Age: Adults Gender: Female
    Trial protocol: NL (Completed)
    Trial results: (No results available)
    EudraCT Number: 2010-023851-27 Sponsor Protocol Number: AMRPhD1 Start Date*: 2012-06-14
    Sponsor Name:Kings College Hospital NHS Foundation Trust
    Full Title: A 12 week, multi centre, open label study to evaluate the effect of fesoterodine flexible dosing regimen on the sexual function of women with overactive bladder.
    Medical condition: sexual function of women with overactive bladder syndrome
    Disease: Version SOC Term Classification Code Term Level
    18.1 100000004872 10040482 Sexual function abnormal LLT
    18.0 100000004857 10059617 Overactive bladder LLT
    Population Age: Adults, Elderly Gender: Female
    Trial protocol: GB (Completed)
    Trial results: View results
    EudraCT Number: 2008-001055-21 Sponsor Protocol Number: H6D-CR-S024 Start Date*: 2008-07-30
    Sponsor Name:Eli Lilly and Company Limited
    Full Title: A Comparison of Psychosocial Outcomes Following Tadalafil Once a Day or PDE5 Inhibitor As Needed in Men With Erectile Dysfunction.
    Medical condition: Erectile Dysfunction
    Disease: Version SOC Term Classification Code Term Level
    9.1 10052003 Erectile dysfunction NOS LLT
    Population Age: Adults, Elderly Gender: Male
    Trial protocol: GB (Completed) DE (Completed) IT (Completed) ES (Completed)
    Trial results: View results
    EudraCT Number: 2006-005139-61 Sponsor Protocol Number: EB064 Start Date*: 2006-10-24
    Sponsor Name:Emotional Brain
    Full Title: Neural correlates of sexual arousal during treatment of testosterone combined with sildenafil in healthy female subjects with FSD. Effects of differing levels of attentional engagement on neural co...
    Medical condition: Hypoactive sexual desire disorder and female sexual arousal disorder
    Disease:
    Population Age: Adults Gender: Female
    Trial protocol: NL (Prematurely Ended)
    Trial results: (No results available)
    EudraCT Number: 2007-003343-74 Sponsor Protocol Number: PDS234 Start Date*: 2007-10-30
    Sponsor Name:Academic Medical Center
    Full Title: A methodological investigation to test acute changes in female sexual desire in healthy volunteersand pre- and postmenopausal women diagnosed with hypoactive sexual desiredisordersusing explicit me...
    Medical condition: hypoactive sexual desire disorder in women (HSDD)
    Disease: Version SOC Term Classification Code Term Level
    9.1 10062641 Female sexual arousal disorder LLT
    Population Age: Adults Gender: Female
    Trial protocol: NL (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2007-002009-31 Sponsor Protocol Number: EB069 Start Date*: 2007-06-13
    Sponsor Name:Emotional Brain BV
    Full Title: A double blind randomized placebo controlled cross-over study to validate the distinction between women with different levels of attention and valence direction for erotic stimuli, in relation with...
    Medical condition: Hypoactive sexual desire disorder and female sexual arousal disorder
    Disease:
    Population Age: Adults Gender: Female
    Trial protocol: NL (Prematurely Ended)
    Trial results: (No results available)
    Download Options:
    Number of Trials to download:
    Download Content:
    Download Format:
    Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.
    1  2  3  4  5  6  Next»
    Query did not match any studies.
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Fri May 09 06:41:59 CEST 2025 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA